Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway

Breast Cancer: Targets and Therapy · Published 2026-03-01 · DOI 10.2147/bctt.s580570

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/bctt.s580570

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles